Neuromodulation of pharyngeal nerves to treat diseases
US-2024366279-A1 · Nov 7, 2024 · US
US10499981B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10499981-B2 |
| Application number | US-201815878326-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 23, 2018 |
| Priority date | Mar 13, 2013 |
| Publication date | Dec 10, 2019 |
| Grant date | Dec 10, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An intrauterine device includes an articulating array. The intrauterine device can be operated by articulating the articulating array into an installed position or geometry within the uterus of a patient. Further, the articulating array can be constructed to include an insertion geometry have a smaller cross section than an installation geometry. The articulating array can also be constructed to be housed within a sheath in the intrauterine device. Once the sheath has been inserted into a patient, for example through the patient's cervix, the articulating array can be deployed in its insertion geometry and then articulated into an installed position. The articulating array can include a plurality of expansion chambers. The expansion chambers can be constructed and arranged to take on the installed geometry when expanded. In one embodiment, the purpose of the articulating array is to position a conductive array within the patient's uterus enabling ablation of the uterine lining.
Opening claim text (preview).
What is claimed is: 1. An intrauterine ablation device, comprising: a sheath configured for transcervical introduction; an articulating array slidably disposed within the sheath and comprising at least three serially disposed expansion chambers, the articulating array having an insertion geometry in which the expansion chambers are linearly aligned in a deflated configuration that may be inserted into a uterus through the sheath, and an installed geometry, in which the expansion chambers are inflated and are rolled into a non-linear configuration; a conductive array disposed on a surface of the articulating array, wherein the conductive array is configured to contact uterine wall tissue when the conductive array is inserted into the uterus and transitioned to the installed geometry; and a port configured to receive an inflation media, wherein delivery of the inflation media to the expansion chambers causes the articulating array to transition from the insertion geometry to the installed geometry. 2. The intrauterine ablation device of claim 1 , the at least three serially disposed expansion chambers of the articulating array including at least first, second and third expansion chambers, wherein the second expansion chamber is disposed between the first and third expansion chambers, so that a proximal portion of the second expansion chamber is disposed adjacent to a distal portion of the first expansion chamber, and a distal portion of the second expansion chamber is disposed adjacent to a proximal portion of the third expansion chamber, wherein when the articulating array is positioned within a uterus via the sheath, and transitioned from the insertion geometry to the installed geometry, the respective first, second and third expansion chambers place the conductive array into contact with uterine wall tissue. 3. The intrauterine device of claim 1 , wherein the conductive array comprises a mesh structure. 4. The intrauterine device of claim 1 , wherein the articulating array further comprises a plurality of channels fluidly coupled to the expansion chambers for delivering and/or withdrawing the inflation media to the expansion chambers through the channels. 5. The intrauterine device of claim 1 , wherein inflation of the expansion chambers causes the articulating array to transition from the insertion geometry into the installed geometry. 6. The intrauterine device of claim 1 , wherein the installed geometry comprises a furled frond-like configuration. 7. The intrauterine device of claim 1 , further comprising a contact sensor disposed on an outer surface of the articulating array. 8. The intrauterine device of claim 1 , further comprising a strain gauge coupled to the articulating array. 9. The intrauterine device of claim 1 , further comprising at least one sensor configured to sense the installed geometry of the articulating array. 10. The intrauterine device of claim 1 , further comprising at least one inflation member having an inflation lumen fluidly coupled to the expansion chambers, with a proximal end of the inflation member configured for fluidly coupling the inflation lumen with a source of inflation media. 11. The intrauterine device of claim 1 , further comprising a controller configured to control pressure within the expansion chambers so as to transition the articulating array between the insertion geometry and the installed geometry. 12. The intrauterine device of claim 1 , wherein the installed geometry is defined by an elasticity of the expansion chambers. 13. The intrauterine device of claim 1 , wherein the installed geometry is triangular, circular, or diamond-shaped.
Ablation · CPC title
Temperature · CPC title
inflatable (A61B2017/22051 takes precedence) · CPC title
specifically adapted for manipulations within body cavities, e.g. within abdominal or thoracic cavities · CPC title
having a short rigid shaft for accessing the inner body through natural openings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.